Wordt geladen...
Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the United States: Part II - An Updated Analysis of SEER-Medicare Data
BACKGROUND: The influx of new oncologic technologies has changed the treatment landscape of renal cell cancer (RCC) in the last decade. This study updated a previously published paper on the economic burden of RCC in the US by using more recent data to examine the impact of various forms of new onco...
Bewaard in:
| Gepubliceerd in: | Pharmacoeconomics |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885100/ https://ncbi.nlm.nih.gov/pubmed/31286464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-019-00824-2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|